Cargando…
Cannabidiol Reduces Leukemic Cell Size – But Is It Important?
The anti-cancer effect of the plant-derived cannabinoid, cannabidiol, has been widely demonstrated both in vivo and in vitro. However, this body of preclinical work has not been translated into clinical use. Key issues around this failure can be related to narrow dose effects, the cell model used an...
Autores principales: | Kalenderoglou, Nikoletta, Macpherson, Tara, Wright, Karen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364234/ https://www.ncbi.nlm.nih.gov/pubmed/28392768 http://dx.doi.org/10.3389/fphar.2017.00144 |
Ejemplares similares
-
Pharmacovigilance on cannabidiol as an antiepileptic agent
por: Ammendolia, Ilaria, et al.
Publicado: (2023) -
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes
por: Peace, Michelle R., et al.
Publicado: (2016) -
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
por: Millar, Sophie A., et al.
Publicado: (2018) -
Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020) -
Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2021)